The burgeoning issue of central line-associated bloodstream infection (CLABSI) rates recorded in the Intensive Care Units (ICUs) of China has been the subject of considerable debate for substantial reasons. A recent study, aimed at providing a precise evaluation of these rates, embraced a meta-analysis approach encompassing 23 studies sourced from various platforms that include PubMed, Web of Science, Embase, CNKI, Wanfang, and Weipu. This extensive exercise which meticulously follows the PRISMA guidelines, covers a timespan from January 2008 to December 2023.
The incorporation of strict literature-selection and data-extraction criteria ensured that the resultant evaluation remained contextually relevant and accurate. Leveraging the random-effects model, the meta-analysis revealed an overarching weighted CLABSI rate of 2.65‰ in China’s ICUs, with slightly more elevated rates in adult ICUs (3.12‰) as compared to pediatric ICUs (2.57‰). Intriguingly, adult ICUs in the northern China region recorded the highest observed rate of 5.13‰ whereas, pediatric ICUs in the eastern China displayed a rate of 3.35‰.
Evidence drawn from this particular study indicates an elevation in CLABSI rates as compared to those disclosed in national and US CDC-NHSN healthcare reports. A call to action is crucially highlighted for intensified surveillance and infection control in a bid to contain these escalating rates. The findings from the study also stress on the imperative need for adoption of standardized surveillance definitions and methodologies that can ultimately result in effective development and application of preventive strategies.
The gravity of the situation reflected in the study’s findings underlines the immediate requirement for a robust response from the medical community. The work aligns with the goal of transparent reporting and academic integrity. This contribution to medical science, authored by Xiang, Cai, Jiang, Chen, Wu, and Lv, belongs to the Sichuan Academy of Medical Sciences and Sichuan Provincial People’s Hospital, Chengdu, China.
Source: https://www.frontiersin.org/journals/public-health/articles/10.3389/fpubh.2025.1480428/abstract